These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18485029)

  • 1. Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction.
    Dinsmore WW; Wyllie MG
    BJU Int; 2008 Sep; 102(8):933-7. PubMed ID: 18485029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.
    Kiely EA; Bloom SR; Williams G
    Br J Urol; 1989 Aug; 64(2):191-4. PubMed ID: 2765789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate.
    Shah PJ; Dinsmore W; Oakes RA; Hackett G
    Curr Med Res Opin; 2007 Oct; 23(10):2577-83. PubMed ID: 17875241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicentre double-blind placebo-controlled study.
    Dinsmore WW; Gingell C; Hackett G; Kell P; Savage D; Oakes R; Frentz GD
    BJU Int; 1999 Feb; 83(3):274-9. PubMed ID: 10233493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide/phentolamine. Invicorp, vasopotin.
    Drugs R D; 1999 Dec; 2(6):436-8. PubMed ID: 10763461
    [No Abstract]   [Full Text] [Related]  

  • 6. A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction.
    Sandhu D; Curless E; Dean J; Hackett G; Liu S; Savage D; Oakes R; Frentz G
    Int J Impot Res; 1999 Apr; 11(2):91-7. PubMed ID: 10356669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal polypeptide and phentolamine mesylate administered by autoinjector in the treatment of patients with erectile dysfunction resistant to other intracavernosal agents.
    Dinsmore WW; Alderdice DK
    Br J Urol; 1998 Mar; 81(3):437-40. PubMed ID: 9523666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors.
    Sung HH; Ahn JS; Kim JJ; Choo SH; Han DH; Lee SW
    Andrology; 2014 Jan; 2(1):45-50. PubMed ID: 24194017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction.
    McMahon CG
    Int J Impot Res; 1996 Dec; 8(4):233-6. PubMed ID: 8981173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure.
    Gerstenberg TC; Metz P; Ottesen B; Fahrenkrug J
    J Urol; 1992 May; 147(5):1277-9. PubMed ID: 1569667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
    Armstrong DK; Convery A; Dinsmore WW
    Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction.
    Padma-Nathan H; Goldstein I; Klimberg I; Coogan C; Auerbach S; Lammers P;
    Int J Impot Res; 2002 Aug; 14(4):266-70. PubMed ID: 12152116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on intracavernosal VIP levels during pharmacologically induced penile erections.
    Kiely EA; Blank MA; Bloom SR; Williams G
    Br J Urol; 1987 Apr; 59(4):334-9. PubMed ID: 2437991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anatomy of drug development: Invicorp, a product before its time.
    Wyllie MG
    BJU Int; 2010 Sep; 106(5):723-4. PubMed ID: 21050351
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies.
    Kim SC; Seo KK; Lee SK; Song ES; Lee MY
    Urol Res; 1999 Dec; 27(6):437-44. PubMed ID: 10651132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the current role of intracavernosal injection in management of erectile dysfunction?
    El-Sakka AI
    Int J Impot Res; 2016 May; 28(3):88-95. PubMed ID: 27076113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.